Wed.Apr 19, 2023

article thumbnail

Expanding The Prescribing Rights of Pharmacists

Drug Topics

Ned Milenkovich, PharmD, JD, joins the Spring 2023 Total Pharmacy Solutions Summit for a seminar on the history and future of prescribing rights within pharmacy.

247
247
article thumbnail

Conditions for worker burnout in biotech are ripe. Here’s how to beat it

PharmaVoice

One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Future Of Community Pharmacy

Drug Topics

Timothy Aungst, PharmD at The Digital Apothecary joined the April 2023 Total Pharmacy Solutions Summit and spoke about how technology and automation continue to grow in the health care world.

article thumbnail

PhRMA awards grant to Emerson Diversity Health Foundation

PhRMA

PhRMA has awarded a $140,000 grant to the Emerson Diversity Health Foundation as part of our commitment to addressing health inequities and enhancing clinical trial diversity.

170
170
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How To Improve Cash Flow In Preparation For DIR Changes

Drug Topics

Dr. Laura Faast joined the Spring 2023 Total Pharmacy Solutions Summit to talk about the best ways pharmacies can improve their cashflow.

247
247
article thumbnail

PhRMA Otorga Beca a la “Emerson Diversity Health Foundation”

PhRMA

PhRMA ha otorgado una beca de 140.000 USD a la “ Emerson Diversity Health Foundation ” como parte de nuestro compromiso de enfrentar la desigualdad en la asistencia médica y aumentar la diversidad de los elegidos para ensayos clínicos.

146
146

More Trending

article thumbnail

Goodbye, original COVID-19 vaccines: FDA updates shot guidance, pulls monovalent authorizations

Fierce Pharma

Goodbye, original COVID-19 vaccines: FDA updates shot guidance, pulls monovalent authorizations zbecker Wed, 04/19/2023 - 11:04

Vaccines 145
article thumbnail

FDA Approves Expanded Indication for Atogepant for Prevention of Chronic Migraine

Drug Topics

Only the 60 mg dose of atogepant is approved for chronic migraine prevention.

FDA 247
article thumbnail

Aflibercept Shows Promising Results for Treatment of wAMD, DME, Diabetic Retinopathy

Pharmacy Times

Data from the aflibercept 8 mg clinical trial program will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, April 23 to 27.

139
139
article thumbnail

Leveraging Clinical Opportunities For Success

Drug Topics

Dean Koskinas, PharmD, is the Execute Sales Consultant at Transaction Data Systems. He joined the Spring 2023 TPSS to discuss the best ways to integrate technology into all aspects of a pharmacy.

247
247
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

US FDA makes EUA changes to Pfizer-BioNTech and Moderna Covid-19 vaccines

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has made changes to the emergency use authorisations (EUAs) of the Pfizer -BioNTech and Moderna bivalent mRNA Covid-19 vaccines. The latest amendment aims to simplify the vaccination schedule for most people. The changes mean that the current bivalent vaccines for the original and Omicron BA.4/BA.5 strains can now be utilised for all doses administered to those aged six months and above.

Vaccines 133
article thumbnail

Expanding Your Pharmacy's Clinical Capabilities

Drug Topics

Paige Clarke, RPh, and Billy Chow, RPh from Prescryptive Health join TPSS to discuss the role of the pharmacist in drug prices, and how to better serve the community.

247
247
article thumbnail

Evening Exercise Lowers Blood Pressure More Than Morning Workouts for Older Individuals

Pharmacy Times

Neurovascular mechanisms cause the decrease in BP levels, results from a study of 23 participants in Brazil show.

132
132
article thumbnail

FDA: Roflumilast Foam NDA Accepted for Seborrheic Dermatitis

Drug Topics

The expected PDUFA date is December 16, 2023.

FDA 247
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Woman of the Week: Brii Biosciences’ Ellee de Groot

PharmaVoice

A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

130
130
article thumbnail

HIMSS23: Best Buy Health, VillageMD execs see collaboration as critical to future of healthcare

Fierce Healthcare

HIMSS23: Best Buy Health, VillageMD execs see collaboration as critical to future of healthcare agliadkovskaya Wed, 04/19/2023 - 15:15

129
129
article thumbnail

After COVID-19 Disruptions, CDC Report Suggests Return to Pre-Pandemic RSV Seasonality

Pharmacy Times

Atypical respiratory syncytial virus epidemics may continue, and testing patients for multiple respiratory pathogens when indicated might be necessary.

129
129
article thumbnail

Discrimination lawsuit against HHMI spotlights barriers faced by scientists with disabilities

STAT

University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic diseases, and in 2008 — when she was on the faculty at the University of Pennsylvania — was hired as a Howard Hughes Medical Institute investigator, an honor for which she received $1 million a year over the next 12 years to further her research.

126
126
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

HIMSS23: Athenahealth rolls out new tool to measure how well patients engage with digital health

Fierce Healthcare

HIMSS23: Athenahealth rolls out new tool to measure how well patients engage with digital health aburky Wed, 04/19/2023 - 16:23

124
124
article thumbnail

Understanding Pharmacokinetics, Pharmacodynamics of Psychedelic Medicines

Pharmacy Times

Pharmacists must be involved in managing adverse effects and drug-drug interactions as psychedelic medicines collide with traditional psychiatric treatments.

123
123
article thumbnail

Elevance Health's profits rise 11% in Q1 to $2B

Fierce Healthcare

Elevance Health's profits rise 11% in Q1 to $2B pminemyer Wed, 04/19/2023 - 07:38

120
120
article thumbnail

FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

Pharmacy Times

Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.

Vaccines 123
article thumbnail

How mobile health apps and self-monitoring enhance patient care

Fierce Healthcare

How mobile health apps and self-monitoring enhance patient care mteefey Wed, 04/19/2023 - 12:47

article thumbnail

Study: Link Seen Between Children Exposed to Opioids During Pregnancy, Chronic Diseases

Pharmacy Times

Analysis shows that babies of mothers who used drugs while pregnant were shorter at birth and weighed less during the breastfeeding stage compared with non-drug-exposed infants.

123
123
article thumbnail

FDA approves allogeneic stem cell transplant therapy

European Pharmaceutical Review

“The approval of Omisirge is a significant development in hematopoietic stem cell transplantation” Omisirge ® (omidubicel-onlv), now US Food and Drug Administration (FDA) approved , is the first allogeneic stem cell transplant therapy to be given marketing authorisation based on results from a global, randomised Phase III clinical study. The treatment is indicated for patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation, following myeloablati

FDA 116
article thumbnail

Researchers Identify Temperature, Humidity Combinations That Stress the Heart

Pharmacy Times

The findings could inform revisions to safety guidelines and policies that help protect people with cardiovascular issues during heat waves.

122
122
article thumbnail

Industry Voices—4 health plan priorities in 2023 and beyond

Fierce Healthcare

Industry Voices—4 health plan priorities in 2023 and beyond pminemyer Thu, 04/20/2023 - 00:21

109
109
article thumbnail

FDA Approves Gamida Cell’s Omisirge for Planned Umbilical Cord Blood Transplantation

Pharmacy Times

Omidubicel-onlv therapy aims to quicken the recovery of neutrophils and reduce the risk of infection in patients with cancer.

FDA 122
article thumbnail

Cardinal Health unveils 2 distribution centers in Central Ohio

Drug Store News

Both facilities will support the company's medical segment, focusing on its U.S. medical products and distribution and at-Home Solutions businesses.

106
106
article thumbnail

SAB secures FDA breakthrough therapy status for influenza immunotherapy

Pharmaceutical Technology

SAB Biotherapeutics has received breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for SAB-176, an investigational immunotherapy to treat influenza. The newly granted status allows SAB to speed up the development and review of SAB-176, which is currently being studied for use in post-exposure prophylaxis for Type A and Type B influenza in high-risk patients, including those with anti-viral resistant strains.

FDA 105
article thumbnail

Bright Health on the hot seat — again — as SSM Health sues for $13M in unpaid claims

Fierce Healthcare

Bright Health on the hot seat — again — as SSM Health sues for $13M in unpaid claims pminemyer Wed, 04/19/2023 - 11:06

105
105
article thumbnail

CDC advisory panel backs changes to Covid vaccination policy

STAT

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule. The Advisory Committee on Immunization Practices was not asked to vote on the changes , announced Tuesday by the Food and Drug Administration.

Vaccines 104
article thumbnail

Bipartisan reps, hospitals back new bill delaying billions in DSH payment cuts to FY2026

Fierce Healthcare

Bipartisan reps, hospitals back new bill delaying billions in DSH payment cuts to FY2026 dmuoio Wed, 04/19/2023 - 12:20

Hospitals 104